Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Dr

Multi-year collaboration to jointly discover, develop, and commercialize novel oncology medicines for up to five programs, with the first ADC program focusing on a SMARCA degraderWILMINGTON, Del. & VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD) and A...

Related Keywords

Vancouver ,British Columbia ,Canada ,United Kingdom ,United States ,British ,Murray Mccutcheon ,Jessica Yingling ,Carl Hansen ,Lindsey Trickett ,Kris Vaddi ,Helen Shik ,Josephine Hellschlienger ,Shik Communications ,Therapeutics Incorporated Prelude Nasdaq ,Linkedin ,Exchange Commission ,Abcellera Biologics Inc ,Business Development ,Prelude Therapeutics Incorporated ,Private Securities Litigation Reform Act ,Financial Condition ,Abcellera Biologics ,Vice President ,Investor Relations ,